Searchable abstracts of presentations at key conferences in endocrinology
ISSN 1470-3947 (print)
| ISSN 1479-6848 (online)
Endocrine Abstracts
Menu
Search
Issues/Conferences
Cite
About
Our Services
Policies
Contact
Disclaimer
Search
Issues/Conferences
Cite
About
Our Services
Policies
Contact
Disclaimer
Previous issue
|
Volume 50
|
SFEBES2017
|
Next issue
Society for Endocrinology BES 2017
Harrogate,
UK
06 Nov 2017 - 08 Nov 2017
All volumes
0102 EYES2024
0101 ETA2024
0100 SFEEU2024
0099 ECE2024
0098 NANETS2023
0097 BES2023
0096 UKINETS2023
0095 BSPED2023
0094 SFEBES2023
0093 EYES2023
0092 ETA2023
0091 SFEEU2023
0090 ECE2023
0089 NANETS2022
0088 BES2022
0087 UKINETS2022
0086 SFEBES2022
0085 BSPED2022
0084 ETA2022
0083 EYES2022
0082 SFEEU2022
0081 ECE2022
0080 UKINETS2021
0079 BES2021
0078 BSPED2021
0077 SFEBES2021
0076 CHD2021
0075 EYES2021
0074 SFENCC2021
0073 ECE2021
0072 UKINETS2020
0071 BES2020
0070 ECE2020
0069 SFENCC2020
0068 UKINETS2019
0067 EYES2019
0066 BSPED2019
0065 SFEBES2019
0064 BES2019
0063 ECE2019
0062 EU2019
0061 OU2019
0060 UKINETS2018
0059 SFEBES2018
0058 BSPED2018
0057 BES2018
0056 ECE2018
0055 SFEEU2018
0054 NuclearReceptors2018
0053 OU2018
0052 UKINETS2017
0051 BSPED2017
0050 SFEBES2017
0049 ECE2017
0048 SFEEU2017
0047 Theranostics2016
0046 UKINETS2016
0045 BSPED2016
0044 SFEBES2016
0043 WCTD2016
0042 Androgens2016
0041 ECE2016
0040 ESEBEC2016
0039 BSPED2015
0038 SFEBES2015
0037 ECE2015
0036 BSPED2014
0035 ECE2014
0034 SFEBES2014
0033 BSPED2013
0032 ECE2013
0031 SFEBES2013
0030 BSPED2012
0029 ICEECE2012
0028 SFEBES2012
0027 BSPED2011
0026 ECE2011
0025 SFEBES2011
0024 BSPED2010
0023 BSPED2009
0022 ECE2010
0021 SFEBES2009
0020 ECE2009
0019 SFEBES2009
0018 MES2008
0017 BSPED2008
0016 ECE2008
0015 SFEBES2008
0014 ECE2007
0013 SFEBES2007
0012 SFE2006
0011 ECE2006
0010 SFE2005
0009 BES2005
0008 SFE2004
0007 BES2004
0006 SFE2003
0005 BES2003
0004 SFE2002
0003 BES2002
0002 SFE2001
SfE BES 2017 will be on the 6-8 November 2016 in Harrogate, UK.
Summary
Abstract Book
Programme
Volume Editors
eposters
Abstracts
Contents
Society for Endocrinology BES 2017
Plenary Lectures
Society for Endocrinology International Medal Lecture
Primary hyperparathyroidism: molecular genetic insights and clinical implications
ea0050pl1
Clinical Endocrinology Trust Lecture
Mechanisms underpinning human insulin resistance
ea0050pl2
Society for Endocrinology Transatlantic Medal Lecture
What to watch: three breakthroughs that may change our lives in the next 10 years
ea0050pl3
Society for Endocrinology Starling Medal Lecture
Next generation tools to understand endocrine function in health and disease
ea0050pl4
Society for Endocrinology Dale Medal Lecture
Abstract unavailable
ea0050pl5
Society for Endocrinology European Medal Lecture
Corticosteroids and the brain
ea0050pl6
Clinical Endocrinology Trust Visiting Professor Lecture
Treatment of radioactive iodine refractory thyroid cancer
ea0050pl7
British Thyroid Association Pitt-Rivers Lecture
Deiodinases and the control of intracellular T3 concentrations
ea0050pl8
Society for Endocrinology Medal Lecture
Adipose tissue expandability, lipotoxicity and the metabolic syndrome
ea0050pl9
Society for Endocrinology Jubilee Lecture
Bacteria, steroids and formyl peptide receptors - more twists to the inflammatory response
ea0050pl10
Society for Endocinology Journal Awards
Society for Endocrinology Journal Award - Journal of Endocrinology
A vital region for human glycoprotein hormone trafficking revealed by an LHB mutation
ea0050ja1
Society for Endocrinology Journal Award - Journal of Molecular Endocrinology
MuRF1 mono-ubiquitinates TR[alpha] to inhibit T3 induced cardiac hypertrophy in vivo
ea0050ja2
Society for Endocrinology Journal Award - Endocrine-Related Cancer
Social isolation induces autophagy in the mouse mammary gland: link to increased mammary cancer risk
ea0050ja3
Society for Endocrinology Journal Award - Clinical Endocrinology
Subcutaneous infusion of kisspeptin-54 stimulates gonadotrophin release in women and the response correlates with basal oestradiol levels
ea0050ja4
Symposia
Steroids and the Skeleton
Abstract unavailable
ea0050s1.1
Skeletal actions of glucocorticoids: Molecular mechanism
ea0050s1.2
Skeletal actions of glucocorticoids - in vivo models
ea0050s1.3
When receptors go rogue
Stress and direct targeting of mitochondrial gene expression by the glucocorticoid receptor in the brain
ea0050s2.1
Dissecting thyroid hormone receptor action
ea0050s2.2
Extra-nuclear estrogen receptors in breast cancer
ea0050s2.3
Fat and Fertility
Obesity, fertility and pregnancy
ea0050s3.1
Abstract unavailable
ea0050s3.2
Abstract unavailable
ea0050s3.3
Pituitary disease in adolescents
Hypothalamic and pituitary stalk lesions in adolescents
ea0050s4.1
Abstract unavailable
ea0050s4.2
Prolactinomas in adolescents
ea0050s4.3
Beyond paragangliomas
SDH mutations in tumourigenesis
ea0050s5.1
Identification of novel therapeutic targets in SDH-mutated cancers: tracing dysfunction
ea0050s5.2
Surveillance imaging strategies in SDHx
ea0050s5.3
Sex hormones through the ages
Menopause guidelines: theory to practice
ea0050s6.1
Brain Mechanisms for the Metabolic Control of Puberty
ea0050s6.2
The genetics of delayed puberty
ea0050s6.3
Taking a risk on love - the endocrinology of behaviour
Risky business - when endocrinology takes over...
ea0050s7.1
Abstract unavailable
ea0050s7.2
Kisspeptin and the control of reproductive behaviour
ea0050s7.3
Adrenal - in health and disease
Reshaping the adrenal cortex: the process of adrenarche
ea0050s8.1
ACTH signalling and resistance
ea0050s8.2
Genomic approach to management of adrenal tumours
ea0050s8.3
Obesity for the Endocrinologist
New drug therapies for obesity: Do they work?
ea0050s9.1
Brain control of appetite
ea0050s9.2
Abstract unavailable
ea0050s9.3
Thyroid cancer- whats hot whats not
Game changers in the clinical management of thyroid cancer
ea0050s10.1
Improving radioiodine uptake in thyroid cancer through NIS induction
ea0050s10.2
Molecular mechanism of thyroid tumourigenesis
ea0050s10.3
New developments in adrenal hypertension
ACTH: an underappreciated driver of hypertension
ea0050s11.1
Adrenal vein sampling vs imaging in primary aldosteronism
ea0050s11.2
Mechanisms of salt-sensitive hypertension
ea0050s11.3
Early Career Symposia
Alternative career pathways
A career in pharma
ea0050ec1.1
A career in teaching or lecturing
ea0050ec1.2
A career in the charitable sector
ea0050ec1.3
A career in publishing
ea0050ec1.4
A career in public health - Leaving the lab to influence individual, community and population health at local, national and international levels
ea0050ec1.5
Clinical Management Workshops
Workshop 1: Collateral damage of cancer treatment
Ovarian function after chemotherapy
ea0050cmw1.1
Abstract unavailable
ea0050cmw1.2
Bone health in cancer survivors
ea0050cmw1.3
Workshop 2: Hyper and Hypocalcaemia
Difficult hypercalcaemia
ea0050cmw2.1
Familial hypocalciuric hypercalcaemia
ea0050cmw2.2
Abstract unavailable
ea0050cmw2.3
Workshop 3: How do I. . . (1)
How do I manage . . . . the patient with thyroid dysfunction after immunotherapy?
ea0050cmw3.1
How do I manage a patient on a bisphosphonate after 5 years?
ea0050cmw3.2
How do I . . . . reconcile inconsistent results in suspected Cushing's?
ea0050cmw3.3
How do I . . . . manage thionamide induced leucopaenia
ea0050cmw3.4
How do I . . . . investigate and manage a patient with Bartter or Gitleman syndrome?
ea0050cmw3.5
How do I . . . . implement patient safety alerts for adrenal insufficiency across my institution
ea0050cmw3.6
Workshop 4: Graves orbitopathy: a Thyronet/ TEAMED
Improving outcomes in thyroid eye disease - the TEAMeD 5 programme
ea0050cmw4.1
Molecular mechanisms of Graves' Orbitopathy
ea0050cmw4.2
Workshop 5: How do I. . . (2)
How do I follow up a patient with an indeterminate non-functioning adrenal nodule?
ea0050cmw5.1
How do I manage a postmenopausal woman asking for testosterone replacement
ea0050cmw5.2
How do I ... approach CVS surveillance in a patient with Turner Syndrome
ea0050cmw5.3
How do I manage Adipsic Diabetes Insipidus
ea0050cmw5.4
How do I manage hypercalcaemia during pregnancy?
ea0050cmw5.5
How do I manage.... myxoedema coma
ea0050cmw5.6
Applied Physiology Workshop
Tissue Engineering for Regenerative Medicine in Endocrinology
Reprogramming gastric tissues for insulin production
ea0050apw1.1
Reprogramming cells to acquire steroidogenic potential: towards therapy for adrenal insufficiency
ea0050apw1.2
3D-Bioprinting coming of age-from cells to organs
ea0050apw1.3
Early Career Prize Lecturese
(1)
Insights into G-protein coupled receptor (GPCR) trafficking and biased signalling by studies of calcium homeostasis
ea0050ecp1.1
The role of hypoxia in the physiology and pathology of menstruation
ea0050ecp1.2
Meet the Expert Sessions
Pitfalls of testosterone replacement in ment
Pitfalls of testosterone replacement in men: Too much of a good thing?
ea0050mte1
Metabolomics and Diet
Modernazing dietary assessment by use of metabolic profiling
ea0050mte2
Autonomous cortisol secretion
Autonomous cortisol secretion
ea0050mte3
The time is right
Controlling for diurnal variation
ea0050mte4
Opiate induced endocrinopathy
Opioid-induced Endocrinopathy: 'Endocrinopathy of Trainspotting'
ea0050mte5
What can next generation sequencing do for you
Abstract unavailable
ea0050mte6
Growth hormone replacement across the ages
Abstract unavailable
ea0050mte7
Highlighting management of hyperthyroidism in pregnancy
Highlighting management of hyperthyroidism in pregnancy
ea0050mte8
Skills
Skills 1: How to engage with the media
Should we engage with the media?
ea0050sk1.1
Science versus the media
ea0050sk1.2
How to react to the media
ea0050sk1.3
Futures
Futures 1: Your future in endocrinology and diabetes
Abstract unavailable
ea0050fut1.1
Why diabetes?
ea0050fut1.2
Clinical academic opportunities in endocrinology
ea0050fut1.3
Futures 2: Consultant careers - Escape options
Medical management: the good, the bad and the ugly
ea0050fut2.1
How to make a success of private practice
ea0050fut2.2
Medico-legal practice: what, why and how?
ea0050fut2.3
Master Class
Masterclass 1: Bone Masterclass
Osteoporosis management: the cutting edge
ea0050mc1.1
A comprehensive secondary fracture prevention strategy
ea0050mc1.2
Masterclass 2: Delivery of specialist endocrine care
Neuroendocrine tumours and the set up in the UK
ea0050mc2.1
Abstract unavailable
ea0050mc2.2
Abstract unavailable
ea0050mc2.3
Abstract unavailable
ea0050mc2.4
Debate
This house believes that the UK population trend in obesity cannot be reversed without food taxation
Debate: this house believes that the UK population trend in obesity cannot be reversed without food taxation
ea0050d1.1
Abstract unavailable
ea0050d1.2
Nurse Session
Nurse Session 1: Cushings disease
Abstract unavailable
ea0050n1.1
Cushing's research - Hot topics
ea0050n1.2
Cushing's disease from a patient's perspective
ea0050n1.3
Nurse Session 2: Diabetes Insipidus
Clinical Presentation and Diagnosis of Cranial Diabetes Inspidus
ea0050n2.1
Abstract unavailable
ea0050n2.2
Challenging cases in DI
ea0050n2.3
Senior Endocrinologists Session
(1)
Reproductive adaptability: Nature's cunning plan
ea0050se1.1
Cancer Survivors-the New Endocrine Epidemic
ea0050se1.2
The mystery of puberty - why it has been such a tough nut to crack?
ea0050se1.3
You think you understand ACTH and Cushing's syndrome?
ea0050se1.4
Oral Communications
Early Career Oral Communications
Neurokinin 3 receptor antagonism is a highly effective, novel treatment for menopausal hot flushes with rapid onset: a phase 2, randomised, double-blind, placebo-controlled trial
ea0050oc1.1
Co-administration of 5[alpha]-reductase inhibitors worsens the adverse metabolic effects of prescribed glucocorticoids
ea0050oc1.2
Antioxidant pathway targeting as a therapeutic approach in adrenocortical carcinoma
ea0050oc1.3
An investigation into sodium-iodide symporter (NIS) dimerization and its impact on radioiodide uptake in thyroid cancer
ea0050oc1.4
An essential physiological role for MCT8 in bone
ea0050oc1.5
Investigating the role of AIP in mouse pituitary adenoma formation
ea0050oc1.6
Clinical Highlights
Mild autonomous cortisol excess in adrenal incidentalomas - metabolic disease burden and urinary steroid metabolome in 1201 prospectively recruited patients
ea0050oc2.1
Combined immunosuppression & radiotherapy in thyroid eye disease (CIRTED) trial: A multi-centre, double-masked, factorial randomised controlled trial
ea0050oc2.2
A novel IGSF1 mutation in a large Irish kindred highlights the need for systematic familial endocrine screening in the IGSF1 deficiency syndrome
ea0050oc2.3
Development of endocrinopathy following treatment of metastatic melanoma with an immune checkpoint inhibitor is associated with better response
ea0050oc2.4
Additional value of 4D-CT in patients with primary hyperparathyroidism and negative conventional imaging; a reason to change primary imaging modality in patients over 60?
ea0050oc2.5
Reduced early GLP-1 response in gestational diabetes is associated with hyperinsulinaemia and insulin resistance: a prospective case-control study
ea0050oc2.6
Obesity, Diabetes Thyroid
Perchlorate exposure affects thyroid function in third trimester pregnant women from South-West England
ea0050oc3.1
Hypothyroidism is a risk factor for acquiring diabetes in women with Turner Syndrome
ea0050oc3.2
The GLP-1R agonist exendin-4 reduces cerebrospinal fluid secretion and intracranial pressure
ea0050oc3.3
Neutrophil elastase-mediated regulation of adipose glucocorticoid exposure through CBG cleavage
ea0050oc3.4
Increased global long interspersed nucleotide element 1 DNA methylation in type 2 diabetes mellitus individuals relates to lower blood pressure and BMI
ea0050oc3.5
Identification of novel sodium iodide symporter interactors which modulate iodide uptake
ea0050oc3.6
Adrenal and Steroids
Predicted benign and silent SNPs in CYP11A1 cause primary adrenal insufficiency through missplicing
ea0050oc4.1
Glucocorticoids rapidly inhibit cell migration through a novel, non-transcriptional pathway involving HDAC6
ea0050oc4.2
Local reactivation of glucocorticoids by 11[beta]-HSD1 mediates their detrimental effects on bone
ea0050oc4.3
The role of [ldquo]stress[rdquo] in aldosterone-mediated hypertension: circumstantial evidence from the [ldquo]stress subtraction[rdquo] experiment of adrenal vein sampling
ea0050oc4.4
NAD+ availability modulates 11[beta]-HSD1 mediated glucocorticoid regeneration in mouse skeletal muscle
ea0050oc4.5
Distinct patterns of glucocorticoid metabolism in patients with HNF1A-MODY have the potential to confer a beneficial metabolic phenotype
ea0050oc4.6
Reproduction and Neuroendocrinology
Increased sertoli cell proliferation and sperm production in FSTL3 deleted mice
ea0050oc5.1
Kisspeptin modulates resting brain activity to alter responses to negative stimuli in humans
ea0050oc5.2
Decoding the functional significance of follicle stimulating hormone glycosylation variants
ea0050oc5.3
Reactive oxygen species as a novel metabolic pathway for sperm DNA damage and Recurrent Pregnancy Loss
ea0050oc5.4
Vitamin-D and fetomaternal immunity: next generation RNA sequence analysis reveals unique effects upon uterine natural killer cells
ea0050oc5.5
The MAPK effector B-Raf is essential for hypothalamic-pituitary axis development and activating mutations in BRAF cause congenital hypopituitarism
ea0050oc5.6
Bone, Calcium and Neoplasia
Photoperiod-induced central actions of thyroid hormone are essential for medullary bone formation
ea0050oc6.1
Glucocorticoids activation by 11beta-hydroxysteroid dehydrogenase type 1 protects against inflammatory bone loss in a murine model of chronic inflammation
ea0050oc6.2
Generation of multiple endocrine neoplasia type 1 and death-domain-associated protein pluripotent stem cell lines to investigate mechanisms of pancreatic neuroendocrine tumourigenesis
ea0050oc6.3
G-protein coupled oestrogen receptor mediates Hippo pathway signalling and survival outcomes in colorectal cancer patients
ea0050oc6.4
Tumor immunosuppressive environment and tamoxifen resistance in rats exposed to EE2 in utero can be prevented with HDAC and DNMT inhibitors
ea0050oc6.5
Calcium-sensing receptor (CaSR) mutations in hypercalcaemic and hypocalcaemic patients cluster at the extracellular dimer interface
ea0050oc6.6
Poster Presentations
Adrenal and Steroids
PAPS synthase 2 is the major PAPS-supplying enzyme for DHEA sulfation
ea0050p001
ARID1a, a SWI/SNF subunit, is important for the regulation of a subset of glucocorticoid responsive genes
ea0050p002
Intra-adrenal cytokine expression during inflammatory stress is immune-dependent
ea0050p003
Development of a liquid chromatography tandem mass spectrometry assay for the profiling of salivary androgens and gestagens
ea0050p004
20[beta]-Dihydrocortisol; a weak endogenous agonist of the glucocorticoid receptor but a potent agonist of the mineralocorticoid receptor
ea0050p005
Improving the therapeutic index of topical anti-inflammatory steroids: angiostatic effects of 5[alpha]-tetrahydrocorticosterone vs hydrocortisone
ea0050p006
Salivary cortisol response to the short Synacthen® test provides a reliable alternative to serum measurement in the assessment of suspected hypoadrenalism
ea0050p007
Is renin a useful marker of mineralocorticoid replacement in addison's disease?
ea0050p008
Using mouse adrenocortical cell lines to investigate how glucocorticoid synthesis is dynamically regulated
ea0050p009
The impact of a point-of-care rapid cortisol assay on success rate, procedural efficiency and radiation dose in adrenal vein sampling for primary hyperaldosteronism
ea0050p010
Does cortisol exposure from the Hydrocortisone day curve predict mortality, type II Diabetes or lipid profiles?
ea0050p011
It's a matter of time: the emergence of autoimmune polyendocrine syndrome in autoimmune Addison's disease reaches 100% among those diagnosed more than 50 years ago
ea0050p012
Short synacthen test requests may be reduced by considering test indication and identifying a 9am cortisol value that predicts test result
ea0050p013
Enteric coating delays the absorption of prednisolone variably and should not be used
ea0050p014
How relevant is aldosterone and cortisol co-secretion?
ea0050p015
The potential use of I-131 Norcholesterol scan for large adrenal mass
ea0050p016
Prednisolone should be first line replacement therapy for adrenal insufficiency
ea0050p018
Does higher cortisol exposure during hydrocortisone replacement therapy lead to osteoporosis?
ea0050p019
How accurate are urinary metanephrines in screening for phaeochromocytoma?
ea0050p020
Clinical implications of the short synacthen test: an audit of its rational use in the assessment of adrenocortical insufficiency
ea0050p021
The effect of 4,4′ DDT, 4,4′ DDE, 4,4′ DDD, and 2,4′ DDD on dihydrotestosterone binding to and releasing from the androgen receptor
ea0050p022
Quality of life in patients with adrenal disease: a systematic review
ea0050p023
Hyperandrogenism secondary to congenital portal hypertension
ea0050p024
Epidemiology of PPGLs - A population based approach
ea0050p025
Ipilimumab induced hypophysitis
ea0050p026
A comparison between short synacthen and long synacthen results in clinical decision making
ea0050p027
Adrenal Incidentalomas- A Retrospective Analysis
ea0050p028
The 2 year half-life of i.m. Trenbolone
ea0050p029
Influence of vitamin D on outcomes following burn injury: An observational cohort study
ea0050p030
Hypoadrenalism, Short Synacthen Test (SST) outcomes and glucocorticosteroid prescribing trend; A large private hospital experience in United Arab Emirates (UAE)
ea0050p031
Large functional adrenocortical carcinoma presenting with hyperandrogenism and hypercortisolism
ea0050p032
Can your hair tell your secret?
ea0050p033
Management of ectopic ACTH syndrome: The birmingham experience
ea0050p034
Bone and Calcium
Studies of nuclear factor I/X (NFIX) mutations causing the Marshall-Smith syndrome (MSS)
ea0050p041
LC-MS/MS measurement of parathyroid hormone PTH (1-34): Use in studying oral PTH (1-34) administration and possible diagnostic application in pseudohypoparathyroidism
ea0050p042
Immunomodulation by vitamin D is associated with regulation of dendritic cell microRNAs
ea0050p043
Disruption of the G-protein subunit [alpha]11 (G[alpha]11) interdomain interface causes autosomal dominant hypocalcemia type-2 (ADH2)
ea0050p044
Uniparental isodisomy as a cause of the autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED) syndrome
ea0050p045
Systematic in silico evaluation of rare genetic variants in G-protein alpha 11 (G[alpha]11)
ea0050p046
A study on 24 hour urine calcium creatinine ratio in primary hyperparathyroidism (PHPT) and familial hypocalciuric hypercalcaemia (FHH)
ea0050p047
Annual incidence of acute severe hypocalcaemia due to hypoparathyroidism: a 3 year consecutive study amongst patients with severe hypocalcaemia presenting to A&E
ea0050p048
Predictors of nephrolithiasis, osteoporosis and mortality in primary hyperparathyroidism
ea0050p049
Discontinuation of denosumab-real world experience from a single centre
ea0050p050
1,25-dihydroxyvitamin D deficiency in haemodialysis patients is corrected by vitamin D supplementation
ea0050p051
Retrospective audit of the use of cinacalcet for the treatment of primary hyperparathyroidism in adults against the NHS England prescribing criteria
ea0050p052
Critical evaluation of biochemical and imaging diagnostic assessment in primary hyperparathyroidism
ea0050p053
Review of denosumab therapy In a Scottish population
ea0050p054
The incidence of Bisphosphonate related Osteonecrosis of the Jaw (BONJ) in patients treated with oral bisphosphonates for osteoporosis
ea0050p055
Audit on parathyroid scans in patients with surgically managed primary hyperparathyroidism
ea0050p056
Imaging in primary hyperparathyroidism; does it affect our referral pathways for surgery? Results of an audit
ea0050p057
Audit of adjusted calcium and serum 25-OH vitamin D screening and replacement therapy prior to Zoledronic acid infusion at University Hospitals Birmingham
ea0050p058
Spontaneous inpatient parathyroid autoinfarction and remission of primary hyperparathyroidism from a mediastinal adenoma
ea0050p059
Review of parathyroid imaging and subsequent surgical findings in primary hyperparathyroidism - do they correlate?
ea0050p060
Prevalence of Kidney Stones and Osteoporosis in Patients with Primary Hyperparathyroidism (PHPT)
ea0050p061
Delphi panel to define patients with chronic hypoparathyroidism 'not adequately controlled on standard therapy'
ea0050p062
A difficult case of metastatic parathyroid cancer with refractory hypercalcaemia and medication-related osteonecrosis of the jaw
ea0050p063
Milk-alkali syndrome in the post PPI era
ea0050p064
Primary hyperparathyroidism - A retrospective review
ea0050p065
Bilateral atypical femoral fractures after only 4-years of bisphosphonate therapy
ea0050p066
Playing tennis with off the chart Calcium levels !!
ea0050p067
Clinical Biochemistry
Personalized medicine and endocrine disorders: the challenges of interpreting genetic variants
ea0050p181
Clinical evaluation of a multiple-gene sequencing panel for hypoparathyroidism
ea0050p182
The free androgen index in women is inaccurate when the SHBG concentration is low
ea0050p183
Interference of midodrine and desglymidodrine in a plasma metanephrines LC-MS/MS assay
ea0050p184
Development of a sensitive, rapid LC-MS/MS method for detection of oxytocin in human plasma
ea0050p185
Lodotra (delayed release prednisone) is variably absorbed, and should not be used in adrenal insufficiency
ea0050p186
How well can we measure SHBG?
ea0050p187
The state of glutathione system in patients with type 2 diabetes
ea0050p188
Diagnosis and management of hyponatraemia in patients with cancer
ea0050p189
An unusual case of Gynaecomastia from hCG secreting bladder cancer
ea0050p190
An audit of the management of patients presenting with hyponatraemia
ea0050p191
The investigation of hyponatraemia in hospitalised patients: an audit
ea0050p193
A well recognised but forgotten cause of undetectable Magnesium
ea0050p194
Diabetes and Cardiovascular
Magnesium modulates the expression of INSR and GLUT4 in streptozotocin-nicotinamide-induced type-2 diabetic rats
ea0050p201
Selective expresssion of one specific isoform of the coxsackie adenovirus receptor (CAR) in the human pancreatic beta cells
ea0050p202
Induced maturity affects normal beta cell function
ea0050p203
Effect of vitamin B12 deficiency on the lipid lowering effect of metformin in the liver
ea0050p204
The effect of escalating doses of beta-blockers and ACE inhibitors on mortality in patients with heart failure and diabetes mellitus
ea0050p205
The impact of a dedicated metabolic hepatology clinic for the treatment of non-alcoholic fatty liver disease
ea0050p206
The impact of a dedicated metabolic hepatology clinic for the treatment of non-alcoholic fatty liver disease
ea0050p207
Do glucocorticoids cause mitochondrial substrate switching in fetal cardiomyocytes?
ea0050p208
Assessment of glycated haemoglobin among HIV patients pre and post highly active antiretroviral therapy (HAART) in Kano, Northwestern Nigeria
ea0050p209
The effect of obesity on cardiovascular risk profile and microvascular disease in type 1 diabetes
ea0050p210
Nuclear factor-kappa beta activation and monocyte-endothelial adhesion lead to chemerin induced endothelial cell inflammation
ea0050p211
'Morning sickness in a 60 year old lady' An unusual presentation of an Insulinoma at a northen DGH.
ea0050p212
Genomic instability in type 2 diabetes mellitus patients from Yucatan, Mexico
ea0050p213
Care processes and intermediate outcomes among patients with diabetes mellitus in a tertiary hospital in Southwestern Nigeria: A retrospective review of records
ea0050p214
A clinical conundrum of euglycaemic ketoacidosis
ea0050p215
The adequacy and effectiveness of inpatient diabetes referrals at University Teaching Hospital
ea0050p216
Audit on management of hyperglycaemia and steroid therapy
ea0050p217
Type 1 or type 3c diabetes: a diagnostic dilemma
ea0050p218
Comparison of laboratory-based and near-patient glucose monitoring in critically ill patients
ea0050p219
The diabetologist as a medical columnist: a 7-year experience
ea0050p220
A rare case of diabetes, hypogonadism and arthritis
ea0050p221
Screening for coeliac disease in type 1 DM - A retrospective observational study in Harrogate District Foundation Hospital
ea0050p222
Frequency of nonalcoholic fatty liver diasease in patients with diabetes mellitus
ea0050p223
UHCW audit on SGLT2 inhibitor (SGLT2-i) use
ea0050p224
Peripheral neuropathy and associated factors among type 2 DM patients in FMC Abeokuta
ea0050p225
Gender differences IN glycaemic target in patient with type 2 DM at the obafemi awolowo university teaching hospitals complex ile-ife South West Nigeria
ea0050p226
Assessing the knowledge of diabetes management within psychiatric crisis resolution teams
ea0050p227
Predictors of hypoglycemia in patients with type 2 diabetes mellitus in South Western, Nigeria
ea0050p228
Antenatal gestational diabetes mellitus care - An audit on follow-up visits and antenatal attendance
ea0050p229
Burden of obesity and hypertension in Nigerians with type 2 diabetes mellitus seen in a tertiary health facility
ea0050p230
Diabetes clinic assessment: lookingout for diabetics' kidneys and toes
ea0050p231
Lifestyle patterns and diabetes risk in second generation South Asians
ea0050p232
The Diabetologist as a Medical Columnist: A 7-year experience
ea0050p233
Transdermal delivery of Syzygium aromaticum-derived oleanolic acid by dermal patches in streptozotocin-induced diabetic rats: effects on some selected metabolic parameters
ea0050p234
Neoplasia, Cancer and Late Effects
Population remodeling in the acquisition of endocrine resistance in breast cancer
ea0050p241
Combination of JQ1, an inhibitor of epigenetic pathways, and everolimus for treatment of pancreatic and bronchial neuroendocrine tumours
ea0050p242
Analysis of the diagnosis, treatment and genetics of 175 cases of phaeochromocytoma and paraganglioma in two ENETS Centres of Excellence
ea0050p243
Identifying linkages between EDCs in personal care products and breast cancer through data integration and gene network analysis
ea0050p244
Assessment of protective factors from the development of radiation induced hypopituitarism: A single centre study
ea0050p245
The course of the endocrine disease in POEMS syndrome
ea0050p246
Check point inhibitor monoclonal antibody therapy - Are there effective markers for endocrine immune-related adverse events?
ea0050p247
In-house method for the detection of miRNA 145 and 21 in plasma samples of breast cancer patients using SYBR green reverse transcription-qPCR
ea0050p248
Multiple endocrine neoplasia type 1 (MEN1) phenocopy due to a P.Leu380Phe cell division cycle 23 (CDC73) mutation
ea0050p249
Immunotherapy and development of endocrine dysfunction: An audit of immune checkpoint inhibitors
ea0050p250
Endocrinopathies are a frequent Consequence of Immune Checkpoint Inhibitor Therapy, with a Low Recovery Rate of both Thyroid and Pituitary Dysfunction
ea0050p251
Primary pulmonary typical carcinoid as a source of ectopic Adrenocorticotropic hormone (ACTH)-dependant Cushing's
ea0050p252
Challenges in diagnosis and management of tumour induced oncogenic osteomalacia
ea0050p253
Giant insulinoma: an unusual cause of hypoglycaemia
ea0050p254
Endocrine adverse effects after immune checkpoint inhibitor therapy in patients with metastatic melanoma: Experience from a single tertiary level centre
ea0050p256
Neuroendocrinology and Pituitary
Morbidity and mortality in patients with hyperprolactinaemia: The prolactin epidemiology, audit, and research study (PROLEARS)
ea0050p261
Establishing the prevalence of pituitary involvement in patients with IgG4-related disease.
ea0050p262
Kisspeptin in the posterodorsal medial amygdala modulates sexual partner preference and anxiety in male mice
ea0050p263
Early post-operative morning serum cortisol measurement as a predictor of remission of Cushing's disease
ea0050p264
Is 11C-methionine PET co-registered with MRI a game changer for persistent acromegaly?
ea0050p265
Patterns of recurrence, response to treatment and mortality in patients with malignant phaeochromocytomas and paragangliomas. - a single centre experience
ea0050p266
11C-methionine PET can aid localisation of the source of ACTH-dependent Cushing's syndrome in patients with equivocal or negative conventional imaging.
ea0050p267
Disorganised anterior pituitary ultrastructure in choriogonadotrophin-alpha (Cga) null female mice
ea0050p268
Male IGSF1 deficient humans and mice exhibit somatotroph neurosecretory hyperfunction
ea0050p269
Smoke-induced nausea; mediated by the release of the lung tachykinin, endokinin, into the circulation?
ea0050p270
Inpatient prescribed desmopressin nasal spray is omitted three times more often than desmopressin prescribed by other routes
ea0050p271
The severity of obstructive sleep apnoea does not influence ambient IGF-I levels
ea0050p272
Cyclooxygenase-2 is a potential target for the treatment of Adamantinomatous craniopharyngioma
ea0050p273
A comprehensive analysis of the AIP mutation positive pituitary tumour microenvironment: role of stromal cells and the pro-inflammatory cytokine network
ea0050p274
Long-term safety of gamma knife radiosurgery (STRS) for acromegaly
ea0050p275
Adherence to Growth Hormone Therapy in Patients with Growth Hormone Deficiency Following Traumatic Brain Injury
ea0050p276
Copeptin during hypertonic saline infusion in a polyuria/polydipsia syndrome case series
ea0050p277
Pituitary function and quality of life in patients taking oral or transdermal opioid analgesics for non-cancer pain
ea0050p278
Bilateral Inferior Petrosal Sinus Sampling (BIPSS) reliably differentiates pituitary from ectopic Cushing's syndrome, but does not predict pituitary tumour location, especially when lateralizing to the right
ea0050p279
Pituitary radiotherapy causes increased, cardio- and cerebrovascular morbidity, and high Age Standardized Mortality Ratio (ASMR): single centre experience
ea0050p280
Comparison of Overnight Dexamethasone Suppression Test with Low Dose Dexamethasone Suppression Test for the Diagnosis of Cushing's Syndrome
ea0050p281
Understanding the psychosocial needs of pituitary patients: a survey of Pituitary Foundation members
ea0050p282
Impact of menopause on the natural history of pre-existing prolactinomas
ea0050p283
Non-functioning pituitary macroadenomas: characteristics and outcomes following endoscopic trans-sphenoidal surgery - a single UK tertiary referral centre experience
ea0050p284
Prevalence of paraganglioma at first screen in SDH mutation carriers identified through family screening
ea0050p285
Acromegaly complication screening - are we meeting the guidelines?
ea0050p286
Inpatient endocrinology referrals: does the RCP report 'Referring Wisely' describe who should be referred?
ea0050p287
Post-surgical treatment outcomes of acromegalic patients
ea0050p288
Treating mild central hypothyroidism in postoperative pituitary patients - impact of Endocrine Society guidelines
ea0050p289
An assessment of hypothalamus-pituitary-adrenal axis post-pituitary surgery: can day 8 morning cortisol predict normal SST?
ea0050p290
Predictors of post-operative hypopituitarism following transsphenoidal surgery
ea0050p291
The burden of arthropathy in acromegaly: results from an observational study
ea0050p292
Cannulated prolactin avoids over-diagnosis and unnecessary investigations in normoprolactinaemic patients
ea0050p293
Outcomes of endoscopic, endo-nasal, trans-sphenoidal pituitary adenoma surgery for Acromegaly and Cushing's disease: A single UK centre experience
ea0050p294
Transitoin from paediatric to adult clinic in endocrinology: an assessment of experience at University College Hospital from the prospective of the adult service
ea0050p295
Connected, supported, informed: experiences & benefits of membership of the pituitary foundation
ea0050p296
Recurrence rate of hyperprolactinemia after dopamine agonists withdrawal in macroprolactinoma patients
ea0050p297
Diagnostic challenges in Cyclical Cushing's syndrome presenting with Bilateral Central Serous Retinopathy
ea0050p298
An Insulinoma presenting post bariatric surgery
ea0050p299
Diagnostic challenge of non-invasive and invasive imaging modalities for insulinoma
ea0050p300
Pituitary tumours and bradycardia/complete heart block-an association or incidental findings?
ea0050p301
Unaffected genetic testing in families at risk of phaeochromocytoma or paraganglioma
ea0050p302
Nursing Practice
The value of a holistic needs assessment tool in the care of patients with acromegaly
ea0050p311
Endocrine clinical nurse specialist nurse led clinics - Legal considerations of practice.
ea0050p312
Audit Outcomes of a Nurse Led, Hyperthyroid Telephone Clinic (HTC)
ea0050p313
UK experience with continuous subcutaneous hydrocortisone infusion in patients with adrenal insufficiency
ea0050p314
Obesity and Metabolism
Advanced NAFLD is common in bariatric surgical patients, poorly staged by non-invasive NAFLD biomarkers and is associated with adverse outcome
ea0050p315
Low vitamin B12 in pregnancy is associated with adipose derived circulating miRNAs targeting PPAR[gamma] and insulin resistance
ea0050p316
The use of intestinal organoids to investigate nutrient sensing
ea0050p317
5[beta]-reductase (AKR1D1) is a potent regulator of carbohydrate and lipid metabolism and inflammation in human liver
ea0050p318
The adverse metabolic phenotype associated with obstructive sleep apnoea is not driven by activation of the hypothalamo-pituitary-adrenal axis
ea0050p319
Androgen excess is highly prevalent in women with idiopathic intracranial hypertension and is biochemically distinct from polycystic ovary syndromes
ea0050p320
Rectal and oral administration of L-Phenylalanine supresses food intake and modulates neuronal activation in appetite-regulating brain regions in rodents
ea0050p321
Cholestatic pregnancy alters the gut incretin response to diet, affecting GLP-1, PYY and FGF19 secretion, with reversal of changes associated with ursodeoxycholic acid treatment
ea0050p322
A randomised controlled trial of vitamin D treatment on markers of liver fibrosis in obese women with Polycystic Ovary Syndrome
ea0050p323
Leptin receptors localise to [beta]-cells in the fetal ovine pancreas, but do not appear to influence [beta]-cell mass in utero
ea0050p324
Evaluating the role of testosterone in cerebrospinal fluid secretion
ea0050p325
Low vitamin B12 induces de novo lipogenesis in human hepatocytes
ea0050p326
Male sexual dysfunction and hypogonadism improves following bariatric surgery
ea0050p327
DNA methylation differs between lean and obese placenta and is influenced by maternal environment and fetal sex
ea0050p328
Vitamin B12 deficiency triggers adipocyte dysfunction by enhancing triglyceride biosynthesis and pro-inflammatory cytokine production: a new agonist in metabolic disease?
ea0050p329
Blunt response to a stress test and higher prevalence of risk polymorphism of glucocorticoid receptor gene (NC3C1) in obese patients
ea0050p330
Alterations in concentration and characteristics of circulating extracellular vesicles in morbid obesity
ea0050p331
Reverse cholesterol transport and other functions of high density lipoprotein are enhanced after bariatric surgery
ea0050p332
Genes involved in zinc homeostasis are associated with metabolic syndrome and insulin resistance in Romanian and French populations
ea0050p333
Low iliac skinfold thickness predict mortality in a prospective cohort of white males
ea0050p334
Investigating the role of Annexin A1 in Adipogenesis and its ability to dampen Obesity associated Inflammation
ea0050p335
Metabolic phenotype of Male Obesity-associated Secondary Hypogonadism pre- and post-replacement therapy with intra-muscular Testosterone undecanoate therapy
ea0050p336
Effect of Roux-en-Y bariatric surgery on lipoproteins, insulin resistance, and systemic and vascular inflammation in obese patients with and without diabetes
ea0050p337
Body fat distribution by dual energy x-ray absorptiometry (DXA) and metabolic risk factors in intravenous glucose tolerance test (IVGTT)-defined high and low insulin sensitivity normoglycaemic, overweight men
ea0050p338
The Prevalence of Obstructive Sleep Apnoea in women with Polycystic Ovary Syndrome: a Systematic Review and Meta-analysis
ea0050p339
Vitamin D status before and after bariatric surgery during 4 years of follow-up
ea0050p340
Resistant Hypertriglyceridemia in pregnancy
ea0050p341
Anthropometric changes associated with antiretroviral therapy in nigerians infected with human immunodeficiency virus
ea0050p342
The challenges of reducing calorie intake in everyday life- a pilot study
ea0050p343
Metabolic profile in a semi urban community in South western Nigeria
ea0050p344
The challanges faced in managing gycogen storage disease
ea0050p345
Reproduction
Mass spectrometry-based assessment of androgen excess in 1205 consecutive patients over 5 years: PCOS most common diagnosis, but severe androgen excess indicates other ovarian and adrenal pathology
ea0050p351
A comparison of Ovarian Hyperstimulation Syndrome (OHSS) parameters following different triggers of oocyte maturation during IVF Treatment
ea0050p352
Polycystic ovary syndrome is associated with adverse mental health and neurodevelopmental outcomes: a retrospective, observational study
ea0050p353
Metformin improves oestrous cycle, ova count and expression of oestrogen receptors in diabetic female Sprague-Dawley rats.
ea0050p354
RNA-Sequencing reveals a downregulation of cholesterol metabolism pathways in granulosa cells from women with PCOS
ea0050p355
Impact of delayed pubertal induction and route of estrogen administration on health parameters in adults with Turner Syndrome
ea0050p356
Metabolic syndrome reduce gravid uterine contractility in female sprague-dawley rat
ea0050p357
Pregnancy, pre-eclampsia and vitamin D: a multi-scale mathematical approach
ea0050p358
Is serial urinary progesterone measured via automated chemiluminescent assay a valid alternative to pregnanediol via manual ELISA for the detection of ovulation?
ea0050p359
Aberrant fetal development precipitated by genistein is accompanied with disruption in the Giant Trophoblast cell histomorphometry, and alteration in the serum, placenta and the amniotic fluid oxidation-reduction system
ea0050p360
Non-cardiac maternal and fetal outcomes in Turner Syndrome pregnancies.
ea0050p361
Kisspeptin-leptin interplay in assisted reproductive techniques
ea0050p362
Effects of myoinositol and D-chiro inositol on hyperandrogenism and ovulation in women with polycystic ovary syndrome: a systematic review
ea0050p363
Aortic dissection in Turner syndrome: a single centre experience
ea0050p364
Effects of feed supplementation with olive oil on serum testosterone, triiodothyronine, thyroxine and some biochemical metabolites in Teddy goat bucks
ea0050p365
Audit of endocrine investigations undertaken in females with elevated testosterone
ea0050p366
Turner syndrome management. Are we going along with the new clinical guidelines?
ea0050p367
Polycystic Ovarian Syndrome (PCOS): Social situation influences Cardiometabolic Outcome
ea0050p368
Polycystic Ovarian Syndrome: Assessment of approaches to diagnosis and cardiometabolic monitoring in UK primary care
ea0050p369
High prevalence of multimorbidity in overweight and obese women with Polycystic Ovary Syndrome (PCOS)
ea0050p370
Standardisation of care: a quality improvement project in Polycystic Ovary Syndrome (PCOS) clinic
ea0050p371
A rare case of Gestational Hyperandrogenism
ea0050p372
Successful stimulation of spermatogenesis in a man with hypogonadotrophic hypogonadism, azoospermia, previous right orchidectomy and a remaining small left testicle
ea0050p373
Clinical and biochemical evaluation of a 32 year old patient with hypogonadism.
ea0050p374
Thyroid
Genetic variants modify susceptibility to AF in patients on thyroid hormone replacement therapy
ea0050p381
A population-based study of the Epidemiology of Chronic Hypoparathyroidism
ea0050p382
Novel driver mutations in thyroid cancer recurrence
ea0050p383
Urinary Iodine to Creatinine ratio (UI/C) during pregnancy is not associated with adverse obstetric outcomes
ea0050p384
Marked increases in levothyroxine prescribing and laboratory testing following a reduction in the upper end of the TSH reference range
ea0050p385
Prevalence of and factors predicting thyroid dysfunction at the time of ST- and non-ST- elevation myocardial infarction - the ThyrAMI 1 study
ea0050p386
The Oxford Multidisciplinary Thyroid Eye Disease Clinic: Can short waiting times and use of Steroid Sparing Agents reduce total glucocorticoid dose and requirement for surgery/radiotherapy?
ea0050p387
An electronic protocol replicating QOF thyroid alerts improves monitoring but does not help optimise levothyroxine replacement in hypothyroidism in primary care
ea0050p388
Morbidity and Mortality in patients with Chronic Hypoparathyroidism
ea0050p389
Thyrotrophin receptor antibodies (TRAb) and other autoantibodies after treatment of Graves' disease
ea0050p390
Iodine status on the Island of Ireland
ea0050p391
The relationship between free T4 and thyrotropin receptor antibodies is log-linear and negatively influenced by age and smoking in patients with Graves' disease
ea0050p392
Long-term relapse rates following thionamide withdrawal in Graves' thyrotoxicosis and the predictive role of TRAbs
ea0050p393
Investigating the utility of diffusion weighted magnetic resonance Imaging as an adjunct to clinical assessment in Graves' Orbitopathy (GO)
ea0050p394
Recent liothyronine price increases have changed primary care prescription practice, with increased referrals to specialist care
ea0050p395
Association of a promoter BAFF polymorphism in Graves' disease
ea0050p396
Primary versus tertiary care follow-up of low risk well differentiated thyroid cancer
ea0050p397
Predictors of thyroid autoimmunity in Maltese individuals
ea0050p398
Autoantibodies to the thyrotropin receptor in Alemtuzumab-induced thyroid autoimmunity: determination of their biological activity, and possible role as predictive marker of disease
ea0050p399
Activating germline TSHR mutations are rare in adult hyperthyroid patients without autoimmunity and showing diffuse uptake on radionuclide thyroid scintigraphy
ea0050p400
Does presence of 'Coexisting Thyroiditis' affect Radioiodine Uptake in Thyroid Cancer Ablation Doses?
ea0050p401
Evaluation of normal reference range for thyroid uptake of technetium-99 m in a single centre UK population
ea0050p402
Use of glucocorticoids in subacute thyroiditis
ea0050p403
The impact of a profoma introduction on the accuracy and appropriateness of Synacthen testing
ea0050p404
Metoprolol succinate is associated with better quality of life in treatment of grave's disease
ea0050p405
Radioiodine treatment for thyrotoxicosis in a district hospital: a re-audit
ea0050p406
Clinical outcomes following radioiodine therapy in Graves' thyrotoxicosis
ea0050p407
Thyroid Nodules (n=400): Correlation of TI-RADS' score with cytological results
ea0050p408
Orbital decompression surgery for graves' ophthalmopathy
ea0050p409
Adoption of the British Thyroid Association guidelines for the investigation of thyroid nodules: a district general hospital experience
ea0050p410
Audit of Fine Needle Aspiration Cytology in the Management of Thyroid Nodule: 3-year experience from Scunthorpe General Hospital
ea0050p411
A rare case of Moyamoya disease in association with Graves Disease in a Caucasian female
ea0050p412
Radioiodine treatment phone clinic for benign thyroid disease: A service audit and quality improvement project in a large tertiary hospital
ea0050p413
Pitfalls in the diagnosis of TSHoma vs Resistant Thyroid Hormone Syndrome.
ea0050p414
A rare case of carbimazole-induced acute liver failure
ea0050p415
Myopathy and dyshagia cause by Severe Hyperthyroidism
ea0050p416
Results of the Liothyronine audit looking at the improvements seen in over all physical well being, mental concentration & somatic symptoms in patients before & after starting T3+T4 combination
ea0050p417
Thyroid related adverse effects of Alemtuzumab in patients with multiple sclerosis- Experience from a single tertiary level centre
ea0050p418
ePoster Presentations
Adrenal and Steroids
Transient adrenal insufficiency secondary to chronic opioid drug therapy
ea0050ep002
A challenging case of primary aldosteronism presenting in pregnancy
ea0050ep003
An unusual case of acute adrenal insufficiency
ea0050ep004
A rare occurence of adrenal leiomyosarcoma
ea0050ep005
Rare case of bilateral massive adrenal myelolipoma in association with congenital adrenal hyperplasia
ea0050ep006
Respiratory muscle weakness and diaphragmatic failure secondary to cushing's syndrome
ea0050ep007
Glucocorticoid and mineralocorticoid Insufficency on treatment with tramadol
ea0050ep008
Pitfalls in the management of indeterminate adrenal masses
ea0050ep009
Idiopathic spontaneous adrenal haemorrhage in pregnancy
ea0050ep010
Isolated DHEAS elevation causing Hirsutism and Oligomenorrhea - A case report
ea0050ep011
A rare cause of hypertension in pregnancy
ea0050ep012
Puzzling adrenal masses in a patient with hypertension
ea0050ep013
Delayed diagnosis of neurofibromatosis type 1 associated phaeochromocytoma and intussuscepting sigmoid adenocarcinoma
ea0050ep014
A case series of metastatic adrenocortical carcinoma at a tertiary care hospital in UK
ea0050ep015
'Connshing syndrome' as a cause of hypertension: case report
ea0050ep016
Abstract unavailable
ea0050ep017
Iatrogenic cushings syndrome precipitated by fluticasone nasal drops in HIV infected patient
ea0050ep018
Two cidental lesions: a benign adrenal schwannoma and cerebral meningioma
ea0050ep019
The challenge of gender re-assignment in a female pseudohaemaphrodite in a resource poor setting: a case report
ea0050ep020
Shortcomings of the short Synacthen test; a near miss case of Addison's disease
ea0050ep021
When One Diagnosis Reveals Another...
ea0050ep022
Bone and Calcium
MEN -1 with Primary hyperparathyroidism in pregnancy: a report of two cases
ea0050ep023
An Unusual Case of Hypercalcaemia Whilst Severely Hypomagnesaemic
ea0050ep024
Ribbing Disease: An Unusual Cause of Leg Pain in a Young Woman
ea0050ep025
Parathyroid Cysts - An Unusual Cause for Primary Hyperparathyroidism
ea0050ep026
Resistance to 1 hydroxyvitamin D? A challenging case
ea0050ep027
A rare case of hypercalcaemia: Double trouble, with a twist
ea0050ep028
A rare clinical presentation of osteomalacia mimicking bony metastatsis in adult
ea0050ep029
Hypercalcaemic crisis secondary to a large cystic parathyroid adenoma
ea0050ep030
Presenting with hypercalcaemia: 'chicken' or 'egg'?
ea0050ep031
Systemic Mastocytosis: A Rare but Important Cause of Osteoporosis
ea0050ep032
Vitamin D Toxicity & Undetectable Serum Levels - A Conundrum
ea0050ep033
A rare case of combined hyperparathyroidism and thymoma
ea0050ep034
Parathyroid Perils: Efficiently Investigating Hypercalcaemia for Malignancy
ea0050ep035
Intracranial Calcification
ea0050ep036
When remedy becomes toxin-rare cause of hypercalcaemia
ea0050ep037
Calcimimetic effect of alfacalcidol in a patient with unusual occurrence of familial hypocalciuric hypercalcemia (FHH) and primary hyperparathyroidism - Case Report
ea0050ep038
Sclerotic Bone Metastases Diagnosed on DXA
ea0050ep039
Case report on symptomatic hypocalcemia associated with acute severe malaria - need for vigilance
ea0050ep040
Clinical Biochemistry
Sertraline-induced non-hyperinsulinemic hypoglycaemia in a non-diabetic patient : A case report
ea0050ep041
A rare cause of acute severe hyponatraemia secondary to the syndrome of inappropraite anti-diuretic hormone (SIADH) secretion
ea0050ep042
A Case of Hypoglycaemia
ea0050ep043
Investigating an isolated serum alkaline phosphatase: an incidental mediastinal seminoma
ea0050ep044
A curious case of recurrent episodes of multiple-electrolytes derangement
ea0050ep045
Blood glucose control in a pregnant female with Type 1 diabetes and Medium-chain acyl-CoA dehydrogenase deficiency (MCADD)
ea0050ep046
A rare metabolic condition presenting to Ophthalmology
ea0050ep047
Pre-eclampsia as a rare cause of severe hyponatraemia
ea0050ep048
'2' much of a problem with hypoglycaemia
ea0050ep049
Starvation ketoacidosis - a rare but significant metabolic condition
ea0050ep050
Primum Non Nocere - the need for appropriate assessment before starting testosterone therapy
ea0050ep051
Diabetes and Cardiovascular
Hypoglycaemia manifested as transient cardiac arrhythmias in a non-diabetic: a case report
ea0050ep053
Significant improvement in response to the GLP1-agonist 'Liraglutide' following change in injection site
ea0050ep054
Diabetes presenting as spontaneous hypoglycemia. Is it possible?
ea0050ep055
Neoplasia, Cancer and Late Effects
Cardiac Paraganglioma associated with SDHB mutation and elevated 3-methoxytyramine levels
ea0050ep057
A Novel cause of non-islet cell tumour hypoglycaemia
ea0050ep058
Pneumocystis pneumonia in Cushing's syndrome due to ectopic ACTH
ea0050ep059
A rare case of MEN 4 presenting with hypercalcaemia in a patient with microprolactinoma 6 years after the diagnosis
ea0050ep060
Hypertestosteronemia and primary infertility from a mediastinal extragonadal germ cell tumor
ea0050ep061
Parathyroid adenoma, pituitary macroadenoma and raised gastrin levels in a patient with negative genetic testing for Multiple Endocrine Neoplasia Type 1: a mere coincidence?
ea0050ep062
Synchronous endocrine malignancies (adrenocortical carcinoma and metastatic papillary thyroid cancer) - case report
ea0050ep063
Case report of adrenocortical carcinoma in a nigerian woman
ea0050ep064
Neuroendocrinology and Pituitary
A rare case of primary suprasellar meningeal melanocytoma associated with nonfunctional pituitary adenoma
ea0050ep065
Case report: Indolent IgG4 hypophysitis with partial anterior pituitary failure
ea0050ep066
A case of plurihormonal TSHoma presenting as meningitis
ea0050ep067
A mysterious pituitary adenoma
ea0050ep069
Tolosa hunt syndrome: a rare cause of hypopituitarism
ea0050ep070
Cushing's disease caused by pituitary macroadenoma exhibiting Crooke's hyaline changes and immunoreactivity for adrenocorticotrophic hormone and growth hormone
ea0050ep071
Multi-drug resistant hyperprolactinaemia - a rarity or a rising entity?
ea0050ep072
Distracting spontaneous refractory hypoglycaemia
ea0050ep073
Recurrent lymphocytic hypophysitis during two pregnancies: a very rare case
ea0050ep074
A rare case of SDHB mutation in a male individual with pituitary adenoma, and paraganglioma/phaeochromocytoma syndrome
ea0050ep075
Secretory Head and Neck Paraganglioma - A rare entity
ea0050ep076
AIP mutation causing familial pituitary tumours
ea0050ep077
A partial hypopituitarism case that resolved following bariatric surgery
ea0050ep078
Siadh associated with neuromyelitis optica involving hypothalamus
ea0050ep079
Paraneoplastic Cushing's syndrome associated with neuroendocrine tumour of the pancreas: A case report and review of literature
ea0050ep080
A rare case of a functioning retroperitoneal paraganglioma in a patient with recurrent Phaeochromocytoma/Paraganglioma (PPGL)
ea0050ep081
Ipilimumab induced hypophsitis. A new cause for a rare disease
ea0050ep082
Secondary adrenocortical insufficiency and renal impairment in a patient presenting with Hyperprolactinaemia
ea0050ep083
Aggresive Ectopic ACTH production causing Cushing's
ea0050ep084
Severe hypoglycaemia in a woman with secondary hypoadrenalism and an abnormal pituitary stalk, complicating metastatic breast carcinoma
ea0050ep085
Cushing's disease - Case report
ea0050ep086
A 32 Year old Nigeria Male with Azoospermia Who Presented with Bilateral Gynecomastia at The State Specialist Hospital Akure - A Case Report and Review of Literature
ea0050ep087
Was it Growth hormone deficiency?
ea0050ep088
Obesity and Metabolism
Successful use of canagliflozin for treatment of post-bariatric surgery hypoglycaemia unresponsive to other therapy
ea0050ep090
The importance of the lows, and not the just the highs, of glycaemia in critical illness
ea0050ep091
Case Series; Experience of the Management of 2 Patients with Severe Anorexia Nervosa in Sligo University Hospital using the MARSIPAN protocol
ea0050ep092
An unsual case of erectile dysfunction with high total testosterone levels
ea0050ep093
Reproduction
Secondary amenorrhea due to abnormalities of the autosomal chromosomes - Case report
ea0050ep094
Oligo-amenorrhoea - a triple whammy?
ea0050ep095
Triple X syndrome and premature ovarian insufficiency - A case report
ea0050ep096
Unusual presentation of sertoli cell only syndrome with extreme tiredness
ea0050ep097
Siginificant hyperandrogenism in a postmenopausal woman from a likely ovarian source
ea0050ep098
Extremely low HDL-C in a patient with premature ovarian failure: case presentation
ea0050ep099
Thyroid
Thymic hyperplasia in Graves' disease - wait and see, or intervene?
ea0050ep100
Persisting biochemical thyrotoxicosis due to biotin supplementation in a patient with Graves' disease
ea0050ep102
Severe thyroid-associated orbitopathy manifesting two years post total thyroidectomy for follicular carcinoma variant of the thyroid
ea0050ep103
Thyroid FDG-PET positivity; Pattern and implications
ea0050ep104
A case of Graves' disease refractory to radioactive iodine
ea0050ep105
Hyperthyroidism secondary to weight loss supplements
ea0050ep106
A case of clinical parotitis following radioiodine treatment for toxic multinodular goitre
ea0050ep107
Development of Graves' ophthalmopathy post-thyroidectomy: Important lessons for clinical practice
ea0050ep108
Thymic hyperplasia associated with Graves' disease: could thymic surgery be deleterious?
ea0050ep109
Challenges in management of a severe case of Amiodarone induced thyroiditis type 2
ea0050ep110
Nivolumab induced thyroid dysfunction in a 61 year old male with non-small cell lung cancer (NSCLC)
ea0050ep111
Delayed diagnosis of severe secondary hypothyroidism in a patient presenting with mixed hyperlipidaemia and metabolic myositis
ea0050ep112
A case of thyrotoxic hyperemesis
ea0050ep113
An interesting case of cryptogenic stroke in the setting of Graves' disease
ea0050ep114
Featured Clinical Cases
Featured Clinical Cases
Novel
ABCC9
mutation with Cantu syndrome-associated phenotype of hypertrichosis with acromegaloid facial features (HAFF) with coexisting familial pituitary adenoma
ea0050cc01
A case of giant prolactinoma with JAK 2 positive mutation
ea0050cc02
A novel variant in the androgen receptor gene causing familial mild androgen insensitivity syndrome
ea0050cc03
Renin assay interference may conceal the diagnosis of primary aldosteronism
ea0050cc04
Mutational analysis and SDHB immunostaining in bladder paraganglioma
ea0050cc05
Activating mutation in the arginine vasopressin receptor AVPR2 resulting in nephrogenic syndrome of inappropriate antidiuresis in a female
ea0050cc06
Case report of MAX mutation causing bilateral phaeochromocytoma
ea0050cc07
Pseudohypervitaminosis D due to assay interference
ea0050cc08
Deteriorating course of a cystic pituitary lesion during pregnancy
ea0050cc09
Hypoparathyroidism and recurrent hypomagnesaemia since infancy: a rare genetic cause
ea0050cc10